Fred Valeriote
- Biotechnology top 2%
- Marine Sponges and Natural Products 6
- Oncology top 5%
- Cancer Treatment and Pharmacology 6
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis 9
- Hematology top 5%
- Cancer Research top 10%
-
- Cancer therapeutics and mechanisms 15
- Biochemical and Molecular Research 6
-
- Acute Lymphoblastic Leukemia research 15
-
- Effects of Radiation Exposure 7
-
- Chemotherapy-induced organ toxicity mitigation 5
- Co-authors
- Lisa van der PuttenTeresa J. ViettiW. Robert BruceGiovanni SantelliB. E. MeekerFaye A. EggerdingDaniel E. BergsagelGerald Medoff
- Cited by
- BiotechnologyOncologyPharmacology
- Journals
- JNCI Journal of the National Cancer Institute (14 papers)Tetrahedron (2 papers)International Journal of Cancer (2 papers)
- Partner nations
- United StatesCanadaEgypt
In The Last Decade
Fred Valeriote
64 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 111
- Biotechnology 262
- Oncology 526
- Pharmacology 264
- Hematology 155
- Cancer Research 166
Countries citing papers authored by Fred Valeriote
This map shows the geographic impact of Fred Valeriote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Valeriote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Valeriote more than expected).
Fields of papers citing papers by Fred Valeriote
This network shows the impact of papers produced by Fred Valeriote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Valeriote. The network helps show where Fred Valeriote may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fred Valeriote, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 24 | |
| 2 | 2012 | 27 | |
| 3 | 2011 | 50 | |
| 4 | 2010 | 87 | |
| 5 | 2002 | 73 | |
| 6 | 2001 | 32 | |
| 7 | 1998 | 2 | |
| 8 | 1998 | 19 | |
| 9 | Regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors in a GM-CSF-dependent human myeloid leukemia cell line (AML-193) by interleukin-6. | 1996 | 8 |
| 10 | 1990 | 3 | |
| 11 | 1984 | 9 | |
| 12 | Effect of dose fractionation of daunorubicin on survival of leukemic cells. | 1980 | 1 |
| 13 | Influence of continuous infusion of cytosine arabinoside on sequencing with daunorubicin in L1210 leukemia. | 1978 | 2 |
| 14 | Kinetics of both leukemic and normal cell population reduction following 5-azacytidine. | 1975 | 7 |
| 15 | Enhancement of the lethal effects of adriamycin (adria) by combining with other agents. Abstr. | 1975 | 2 |
| 16 | Jag orkar inte mer | 1974 | 49 |
| 17 | Survival of hematopoietic and leukemic colony-forming cells in vivo following the administration of daunorubicin or adriamycin. | 1972 | 29 |
| 18 | Comparison of the cytotoxicity of 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) on normal and leukemic colony-forming cells. | 1971 | 1 |
| 19 | 1968 | 2 | |
| 20 | Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells of mice to vinblastine administered in vivo. | 1966 | 25 |
About Fred Valeriote
Fred Valeriote is a scholar working on Hematology, Biotechnology, Pharmacology, Public Health, Environmental and Occupational Health and Oncology, having authored 65 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (15 papers), Acute Lymphoblastic Leukemia research (15 papers), Microbial Natural Products and Biosynthesis (9 papers), Effects of Radiation Exposure (7 papers), Biochemical and Molecular Research (6 papers), Marine Sponges and Natural Products (6 papers), Cancer Treatment and Pharmacology (6 papers) and Chemotherapy-induced organ toxicity mitigation (5 papers). The work is most often cited by research in Biotechnology (262 citations), Oncology (526 citations), Pharmacology (264 citations), Hematology (155 citations) and Cancer Research (166 citations). Fred Valeriote has collaborated with scholars based in United States, Canada and Egypt. Frequent co-authors include Lisa van der Putten, Teresa J. Vietti, W. Robert Bruce, Giovanni Santelli, B. E. Meeker, Faye A. Eggerding, Daniel E. Bergsagel, Gerald Medoff, Mark Edelstein and William H. Gerwick. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Tetrahedron, International Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.